Background: There is a common pathophysiological basis rooted in insulin resistance for both Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS). Their coexistence significantly amplifies cardiovascular morbidity and mortality. Objective: To evaluate the prevalence of metabolic syndrome (MetS) among patients with Type 2 Diabetes mellitus (T2DM) aged ≥ 30 years and assess the clinical and biochemical correlations between diabetes parameters and components of metabolic syndrome. Methods: A cross-sectional study was conducted over one year in fifty admitted patients aged ≥ 30 years with established T2DM in the Department of General Medicine at Shri Guru Ram Rai Institute of Medical and Health Sciences, Shri Mahant Indiresh Hospital, Dehradun, Uttarakhand, India. Metabolic syndrome was diagnosed using NCEP ATP III criteria. Anthropometric, clinical, and biochemical variables were recorded and analyzed using appropriate statistical tests. Results: Among 50 admitted participants (mean age 53.6 ± 9.1 years), 28 patients (56%) fulfilled criteria for metabolic syndrome. Most prevalent components were Central obesity (72%), hypertension (68%), and low HDL cholesterol (60%). Mean BMI was significantly higher in the metabolic syndrome group (30.4 ±2.6 kg/m²) compared to non-metabolic syndrome group (27.9 ± 2.3 kg/m²; p<0.001). In MetS patients, mean HbA1c levels were also higher (8.6 ± 1.1%) in comparison to non-MetS (7.8 ±0.9%; p=0.02). There were significant positive correlations between waist circumference and triglyceride levels (r=0.48, p=0.003). Conclusion: It was observed that more than half of Type 2 DM patients over 30 years demonstrated metabolic syndrome. Major dominant contributors were central obesity and hypertension. Routine MetS screening should be integrated into diabetes management to reduce cardiovascular risk burden.